NEWS
Jan 22, 2018
NEWS
EVENTS
Medicus Society Members Meeting - April 23, 2023
To all members of Medicus Society. Medicus Society members meeting date is scheduled for 4/23/2023 – Sunday.
Meeting Agenda Society Activity, summary report – Dr. Tadeusz Pyz – President Financial repor...
read moreFIND A DOCTOR
Professor Wacław Szybalski, one of our greatest and best-known Polish scientists, is currently professor emeritus of oncology at the McArdle Laboratory for Cancer Research, University of Wisconsin and a Honorary Member of Medicus Society!
Dr. Szybalski was born in Lwów, Poland on September 9, 1921. He pursued his education and training at the Politechnika Lwowska (currently Lviv Technical University), the Politechnika Śląska (SilesianTechnical University) and the Politechnika Gdańska (Gdańsk Technical University) where he obtained a D.Sc. in Chemistry in 1949. Since 1950 he has lived in the Unites States where he has made major contributions to our understanding of molecular biology and genetics. His significant discoveries have had a major impact on our understanding of life processes and have contributed substantially to the development of therapeutics for a variety of diseases.
Od lewej Dr. Dariusz Konopka, prof. Wacław Szybalski, A. Pastula, Marek Skulimowski prezes KF.
Prof. Waclaw Szybalski w rozmowie z Markiem Skulimowskim, prezesem FK
In the picture: Prof. Wacław Szybalski receives the Grand Cross of the Order of Polonia Restituta (Rebirth of Poland) from President of Poland Bronisław Komorowski in 2011 for his "extraordinary and distinguished service." Photo: Foundation Professor Wacław Szybalski
Dr. Dariusz Konopka, prezes Medicusa i prof. Wacław Szybalski - Honorary Member
Dr. Szybalski early showed signs of his remarkable creativity while still a student at the Politechnika Lwowska (1939-1944). There he devised a method of paper chromatography that found wide application. Soon after, in Denmark (1946-1949), he made important contributions by elucidating the kinetics of certain chemical reactions and by devising a simple method to prevent the corrosion of iron pipes caused by aerobic bacteria. His prolific research output in the United States began with genetic studies of drug resistance that led to the use of multi-drug therapy that is now widely used to treat bacterial infections, viral infections and cancer (1953-1956). His studies of the genetics of the antibiotic-producing soil microorganism, Streptomyces, yielded information that was useful in the commercial production of streptomycin, an effective therapeutic for treating tuberculosis.
